DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Hidayat K, Du X, Shi BM.
Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies.
Osteoporos Int 2019;
30: 1923-1940
We do not assume any responsibility for the contents of the web pages of other providers.